Search the Newsreel

Capitol Federal Financial Inc (CFFN) Stock News Today

This article provides the latest stock news for Capitol Federal Financial Inc (CFFN), including its current stock price, market capitalization, and P/E TTM. It indicates that more news regarding earnings, analyst ratings, and key developments will be available soon.

Mettler-Toledo director Thomas P. Salice disposes of 417 common shares for USD 600,651.00

Mettler-Toledo director Thomas P. Salice sold 417 common shares for USD 600,651.00 on August 5th. Salice also exercised stock options for the same number of shares on the same day at a lower price. After these transactions, he directly owns 292 shares.

HomesToLife Ltd. (HTLM) Analyst insights, Price targets and Recommendations - Yahoo Finance

The article provides real-time stock information for HomesToLife Ltd. (HTLM), including its current price, daily change, and after-hours trading data. It also lists several related tickers and general market indices, along with top gainers, losers, and most active stocks on various exchanges. The content …

Insider Selling: Mettler-Toledo International (NYSE:MTD) Director Sells 417 Shares

Mettler-Toledo International (NYSE:MTD) Director Thomas Salice sold 417 shares of the company's stock for approximately $600,651, reducing his stake by 58.82%. The company recently reported strong quarterly earnings, beating analyst estimates, with revenue up 4.5% year over year. Despite mixed analyst ratings, the consensus …

THOMAS SALICE Exercises Options, Realizes $426K

THOMAS SALICE, a Board Member at Mettler-Toledo Intl (NYSE: MTD), exercised stock options for 417 shares valued at $426,711, as revealed in an SEC filing on August 7. The article also provides a financial overview of Mettler-Toledo Intl, highlighting its revenue growth, debt-to-equity ratio, …

Capitol Federal Financial (NASDAQ: CFFN) 9M income rises to $64M

Noticias de acciones de Bristol-Myers Squibb Co (BMY)

Toll Brothers Announces Final Opportunity to Own a New Luxury Home in Seabrook Village at Nocatee

Toll Brothers announced the final opportunity to purchase a luxury home in Seabrook Village at Nocatee, Ponte Vedra, Florida, with only one residence remaining. The available home, located at 24 Seawatch Lane and featuring the Sparrow Elite design, is priced at $799,000 and will …

The Bull Case For Bristol Myers Squibb (BMY) Could Change Following Expanded Schrödinger Bunsen AI Partnership

ETFs Investing in Mettler-Toledo International Inc. Stocks

This article lists various ETFs that include Mettler-Toledo International Inc. (MTO) stocks in their portfolios, offering investors diversified exposure to the company. The list provides key details for each ETF, such as market value, weight of MTO in the fund, issuer, management style, expense …

What the AstraZeneca-BMS rumors reveal about pharma megamergers

Reports of a potential megamerger between AstraZeneca and Bristol Myers Squibb, which would have created a $400 billion pharmaceutical giant, were quickly disputed. While AstraZeneca's strong pipeline makes a merger less appealing for them, Bristol Myers Squibb could benefit due to impending patent expirations …

Toll Brothers Selling Select Model Homes at Regency at Folsom Ranch in Folsom, California

Toll Brothers is selling nine professionally decorated and fully furnished model homes at Regency at Folsom Ranch, an active-adult community in Folsom, California. These luxury single-story homes, part of the Sequoia, Redwood, and Tahoe Collections, are priced from the upper $800,000s and offer resort-style …

Capitol Federal Financial To Go Ex-Dividend On August 7th, 2026 With 0.085 USD Dividend Per Share

Capitol Federal Financial is scheduled to go ex-dividend on August 7th, 2026. Shareholders on record will receive a dividend of 0.085 USD per share. This information is crucial for investors tracking dividend payouts.

Autoliv (NYSE:ALV) Stands Out for Dividend Quality

5 Insightful Analyst Questions From Mettler-Toledo’s Q2 Earnings Call

Bristol-Myers Squibb’s Q2 Earnings Call: Our Top 5 Analyst Questions

Empowered Funds LLC Acquires New Position in Capitol Federal Financial $CFFN

Toll Brothers Inc. $TOL Shares Sold by Amundi

Amundi reduced its stake in Toll Brothers Inc. (NYSE:TOL) by 31.5% in the first quarter, selling 33,703 shares and retaining 73,250 shares valued at approximately $10 million. Despite some institutional selling, other firms like EverSource Wealth Advisors and Royal Bank of Canada increased their …

Beyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition

Rumors of a potential AstraZeneca-Bristol Myers Squibb merger, despite being disputed, highlight a fundamental shift in pharmaceutical competition. The article suggests that future success in the industry will depend not just on scientific innovation, but on integrated capabilities including AI, resilient manufacturing, and diversified …

Bristol Myers Squibb (BMY) Stock Looks Reasonable Below Fair Value

Toll Brothers Opens Rivington Landing Luxury Condo Community in Danbury, Connecticut

Toll Brothers has opened Rivington Landing, a new luxury condo community in Danbury, Connecticut, located within the Rivington by Toll Brothers master plan. The community offers single-level residences with elevator access, featuring six modern floor plans starting from the low $500,000s, and residents can …

CPI | AstraZeneca, Bristol Myers Dismiss Merger Talk Speculation

AstraZeneca Plc and Bristol Myers Squibb Co. have dismissed speculation regarding a potential merger, stating they are not engaged in such discussions. This clarification came after an earlier report by the Financial Times suggested talks were underway for a $400 billion deal, which caused …

Sei Investments Co. Raises Stock Holdings in Toll Brothers Inc. $TOL

Sei Investments Co. significantly increased its stake in Toll Brothers Inc. (NYSE:TOL) by 69.8% in the first quarter, now owning 40,097 shares valued at $5.47 million. This move is part of broader institutional interest, with such investors holding 91.76% of the company's stock. Despite …

Thomas Salice plans Mettler-Toledo (MTD) stock sale under Form 144

Thomas Salice has filed a Form 144 notice to sell 417 shares of Mettler-Toledo International Inc. common stock, valued at $600,651.01, through Merrill on the NYSE around August 5, 2026. These shares originated from a stock option exercise in 2016. Salice also reported a …

Mettler-Toledo International Inc. stock underperforms Wednesday when compared to competitors

Mettler-Toledo International Inc. (MTD) stock fell 1.08% to $1,421.52 on Wednesday, marking its second consecutive day of losses. This underperformance occurred during a mixed trading session where the Dow Jones Industrial Average rose, but the S&P 500 Index declined. The article notes the stock's …

Mettler-Toledo International (NYSE:MTD) Insider Sells $342,513.60 in Stock

Mettler-Toledo International insider Gerry Keller sold 240 shares of company stock for $342,513.60, reducing his direct ownership by 48.1%. The company recently reported quarterly EPS of $11.46, surpassing analyst estimates, with revenue rising 4.5% year over year to $1.03 billion. Despite positive earnings, analyst …

5 Dividend Stocks Paying Out This Month – But There’s a Catch

Quick Read Five dividend stocks, among them ARLP and BKR, share an August 7 ex-date, so buyers must act by market close on August 6 if they want to collect the next distribution. CFFN and BKR carry the strongest payout coverage, while ARLP's 9% …

Mettler-Toledo International (NYSE:MTD) CFO Shawn Vadala Sells 2,240 Shares of Stock

Mettler-Toledo International (NYSE:MTD) CFO Shawn Vadala recently sold 2,240 shares of the company's stock for over $3.2 million, reducing his direct holdings by 28.65%. This transaction comes as the company reported better-than-expected quarterly earnings with an EPS of $11.46 and revenue of $1.03 billion, …

Mettler Toledo International Insider Sold Shares Worth $342,514, According to a Recent SEC Filing

An insider at Mettler Toledo International recently sold shares valued at $342,514, as detailed in a recent SEC filing. This transaction involved a significant sale of company stock by an insider. The specific details of the sale are publicly available through the SEC filing.

Senior Source Denies AstraZeneca and Bristol Myers Deal Talks : Report

A senior source has denied any ongoing or historical discussions between AstraZeneca and Bristol Myers Squibb regarding a potential merger, contradicting earlier speculation about a nearly $400 billion deal. The denial follows initial reports that caused AstraZeneca's shares to drop, with the subsequent denial …

No deal between AstraZeneca and BMS, senior source insists: Reuters

Reuters has reported that rumors of a merger between AstraZeneca and Bristol Myers Squibb are false, according to a senior source close to the matter. This news deflates widespread speculation about what could have been the largest pharmaceutical deal in history, valued at approximately …

Gerry Keller At Mettler-Toledo Intl Capitalizes: Options Exercised, Resulting In $172K

Gerry Keller, Head Process Analytics at Mettler-Toledo Intl (NYSE: MTD), recently exercised stock options for 240 shares valued at $172,125. The company's financials show a positive revenue trend with a 4.48% growth rate but a high debt-to-equity ratio of 164.7. Mettler-Toledo Intl has a …

Mettler Toledo director Natalia Shuman-Fabbri files initial beneficial ownership statement

Mettler Toledo director Natalia Shuman-Fabbri has filed her initial Form 3 beneficial ownership statement, dated August 3. This news brief was generated by Public Technologies (PUBT) using AI and is based on original content published by Mettler Toledo International Inc. via the SEC's EDGAR …

Is Mettler-Toledo International (MTD) Fully Priced After A 18% Gain?

Senior source denied AstraZeneca and Bristol Myers Squibb were ever in merger talks

A senior source close to the matter denied that AstraZeneca and Bristol Myers Squibb were ever in merger talks, contradicting earlier reports of a potential $400 billion combination. This denial comes after AstraZeneca's shares dropped following the initial reports, while Bristol Myers Squibb's stock …

'No discussions' over AstraZeneca-Bristol Myers deal, senior source says

A senior source close to the matter has stated that there are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb regarding a potential merger, dispelling recent reports of a mega deal. AstraZeneca's shares initially slid after the Financial Times reported on potential talks …